The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Pro Medicus Limited has signed the seven-year contract between subsidiary Visage Imaging and Duke Health.

The contract will see the use of Pro Medicus’ Visage 7 technology being used across Duke’s radiology departments and its electronic health record. The Visage 7 delivers a multi-display, multi-dimensional and referring physician platform to access diagnostic imaging modalities.

It allows radiologists and physicians to interpret images, CT scans, brain scans, and vessel analysis. This technology will offer a faster and more streamlined analysis for health professionals.

Pro Medicus CEO Dr. Sam Hupert believes this partnership will be beneficial to their progress.

“This partnership not only helps consolidate our strong position in this highly competitive market, but it also enables us to leverage our development and commercialisation efforts across an increasing base of academic and research orientated clients,” he said.

Visage 7 will be used across three hospitals and dozens of other locations including the Duke University Hospital.

Is planned to begin rolling out at the end of 2019 with the first sites to implement at the beginning of 2020.

Please find announcement here

PME by the numbers
More From The Market Online

ResMed spikes on robust results and global growth spurt

ResMed shares have climbed following the release of the company's strong Third Quarter FY2024 results.

PharmAust CEO’s sayanora triggers stock plunge

Clinical-stage biotechnology company, PharmAust shares plunged 24 per cent so this morning, following the resignation of…

Unith wraps up Q1 with $5M in cash as digital humans evolve

Unith has wrapped up Q1 of 2024 with nearly $5M in cash and opex reduced. But…

Recce wins safety board approval to dose 4g in R327 UTI infusion trial

Recce Pharma will dose patients with 4g of its R327 intravenous solution to treat UTIs in…